Browsing Tag
Ovid Therapeutics
2 posts
Ovid Therapeutics (NASDAQ: OVID) surges 28% on $175m private placement: What does it mean for biotech investors?
Ovid Therapeutics (NASDAQ: OVID) jumped 28% after securing $175M via a PIPE deal. Explore its pipeline focus, stock sentiment, and investor outlook.
Ovid Therapeutics announces significant workforce reduction to extend cash runway
Ovid Therapeutics Inc., a New York-based biopharmaceutical company, has announced a significant reduction in its workforce. This decision,…